Pre-order Enquiry
Request Free Sample
North America Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
SKU ID : DBMR-11617943 | Publishing Date : 01-Nov-2017 | No. of pages : 350
Detailed TOC of North America Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
TABLE OF CONTENTS1. INTRODUCTION 32
1.1. OBJECTIVES OF THE STUDY 32
1.2. MARKET DEFINITION 32
1.3. OVERVIEW OF NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET 32
1.4. CURRENCY AND PRICING 33
1.5. LIMITATION 33
1.6. MARKETS COVERED 34
2. MARKET SEGMENTATION 38
2.1. MARKETS COVERED 38
2.2. GEOGRAPHIC SCOPE 40
2.3. YEARS CONSIDERED FOR THE STUDY 41
2.4. CURRENCY AND PRICING 41
2.5. RESEARCH METHODOLOGY 42
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.7. SECONDARY SOURCES 47
2.8. ASSUMPTIONS 47
3. MARKET OVERVIEW 48
3.1. DRIVERS 49
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION 49
3.1.2. GROWING NUMBER OF GERIATRIC POPULATION 49
3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS 49
3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT 50
3.1.5. NEW PRODUCT LAUNCHESBY KEY PLAYERS 50
3.2. RESTRAINTS 50
3.2.1. EXPIRY OF PATENT FOR DRUGS 50
3.2.2. WEAK REIMBURSEMENT POLICIES 50
3.2.3. STRINGENT REGULATORY POLICIES 51
3.3. OPPORTUNITIES 51
3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS 51
3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET 51
3.3.3. INCREASING MERGERS AND ACQUISITIONS 51
3.4. CHALLENGES 52
3.4.1. PRICING PRESSURE BY GOVERNMENT 52
3.4.2. SIDE EFFECTSOF TOPICAL CORTICOSTEROIDS 53
4. EXECUTIVE SUMMARY 54
5. PREMIUM INSIGHTS 56
6. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME 59
6.1. OVERVIEW 60
6.2. FLUDROXYCORTIDE 62
6.3. TRIAMCINOLONE ACETONIDE 63
6.4. FLUOCINOLONE ACETONIDE 64
6.5. ANTISEPTICS 65
6.6. BETAMETHASONE 66
6.7. CLOBETASONE PROPIONATE 67
6.8. CLOBETASONE BUTYRATE 68
6.9. HALOBETASONE 69
6.10. MOMETASONE 70
6.11. OTHERS 71
7. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS 72
7.1. OVERVIEW 73
7.2. ULTRA HIGH 75
7.2.1. CLOBETASOL PROPIONATE 76
7.2.2. DIFLORASONE DIACETATE 76
7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL 76
7.3. HIGH 77
7.3.1. AMCINONIDE 78
7.3.2. BETAMETHASONE DIPROPIONATE 78
7.3.3. DESOXIMETASONE 78
7.3.4. FLUOCINONIDE 78
7.3.5. OTHERS 79
7.4. MODERATE 79
7.4.1. DESOXIMETASONE 80
7.4.2. FLUOCINOLONE ACETONIDE 80
7.4.3. FLUDROXYCORTIDE 81
7.4.4. HYDROCORTISONE VALERATE 81
7.4.5. TRIAMCINOLONE ACETONIDE 81
7.4.6. CLOBETASONE BUTYRATE 81
7.4.7. OTHERS 81
7.5. MILD 82
7.5.1. HYDROCORTISONE 83
7.5.2. HYDROCORTISONE ACETATE 83
7.5.3. BETAMETHASONE VALERATE 83
7.5.4. DESONIDE 84
7.5.5. FLUOCINOLONE ACETONIDE 84
7.5.6. OTHERS 84
8. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION 85
8.1. OVERVIEW 86
8.2. ACNE 88
8.3. DERMATITIS 89
8.4. PSORIASIS 89
8.5. SKIN INFECTION 91
8.6. HYPERPIGMENTATION 92
8.7. MELASMA 93
8.8. OTHERS 94
9. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE 95
9.1. OVERVIEW 96
9.2. OINTMENTS 98
9.3. CREAMS 99
9.4. LIQUID & SOLUTIONS 100
9.5. LOTIONS 101
9.6. GEL 102
9.7. OILS 103
9.8. PASTES 104
9.9. SPRAYS 105
9.10. OTHERS 106
10. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER 107
10.1. OVERVIEW 108
10.2. HOSPITAL 110
10.3. DERMATOLOGY CLINICS 111
10.4. HOMECARE 112
10.5. OTHERS 113
11. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET,
BY DISTRIBUTION CHANNEL 114
11.1. OVERVIEW 115
11.2. HOSPITAL PHARMACIES 117
11.3. PHARMACY STORES 118
11.4. ONLINE PHARMACIES 119
11.5. OTHERS 120
12. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE 121
12.1. OVERVIEW 122
12.2. OVER THE COUNTER (OTC) BASED 124
12.3. PRESCRIPTION BASED 125
13. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS 126
13.1. OVERVIEW 127
13.2. BETNOVATE 127
13.3. BETNOVATE N 127
13.4. PANDERM PLUS 128
13.5. LOBATE 128
13.6. COSVATE G 128
13.7. CLOP G 128
13.8. TENOVATE GN 128
13.9. LOBATE GM 128
13.10. ULTIDERM 128
13.11. FLUTIVATE 129
13.12. FEXIN 129
13.13. MOMATE 129
13.14. CANDIDERM 129
13.15. OTHERS 129
14. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY 130
14.1. OVERVIEW 131
14.2. NORTH AMERICA 138
14.2.1. U.S. 151
14.2.2. CANADA 156
14.2.3. MEXICO 161
15. NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE 331
15.1. COMPANY SHARE ANALYSIS: NORTH AMERICA 331
16. COMPANY PROFILES 335
16.1. GLAXOSMITHKLINE PLC. 335
16.1.1. COMPANY OVERVIEW 335
16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS 335
16.1.3. PRODUCT PORTFOLIO 336
16.1.4. RECENT DEVELOPMENTS 336
16.2. MERCK & CO. INC. 337
16.2.1. COMPANY OVERVIEW 337
16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS 337
16.2.3. PRODUCT PORTFOLIO 338
16.2.4. RECENT DEVELOPMENTS 338
16.3. LEO PHARMA 339
16.3.1. COMPANY OVERVIEW 339
16.3.2. LEO PHARMA: REVENUE ANALYSIS 339
16.3.3. PRODUCT PORTFOLIO 340
16.3.4. RECENT DEVELOPMENTS 340
16.4. ALMIRALL S.A. 341
16.4.1. COMPANY OVERVIEW 341
16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT 341
16.4.3. PRODUCT PORTFOLIO 342
16.4.4. RECENT DEVELOPMENTS 342
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL 343
16.5.1. COMPANY OVERVIEW 343
16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS 343
16.5.3. PRODUCT PORTFOLIO 344
16.5.4. RECENT DEVELOPMENTS 344
16.6. ZYLERA PHARMACEUTICALS 345
16.6.1. COMPANY OVERVIEW 345
16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT 345
16.6.3. PRODUCT PORTFOLIO 346
16.6.4. RECENT DEVELOPMENTS 346
16.7. SANDOZ INTERNATIONAL GMBH 347
16.7.1. COMPANY OVERVIEW 347
16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS 347
16.7.3. PRODUCT PORTFOLIO 348
16.7.4. RECENT DEVELOPMENTS 348
16.8. PFIZER INC. 349
16.8.1. COMPANY OVERVIEW 349
16.8.2. PFIZER INC.: REVENUE ANALYSIS 349
16.8.3. PRODUCT PORTFOLIO 350
16.8.4. RECENT DEVELOPMENTS 350
16.9. SANOFI S.A. 351
16.9.1. COMPANY OVERVIEW 351
16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS 351
16.9.3. PRODUCT PORTFOLIO 352
16.9.4. RECENT DEVELOPMENTS 352
16.10. ASTRAZENECA 353
16.10.1. COMPANY OVERVIEW 353
16.10.2. ASTRAZENECA: REVENUE ANALYSIS 353
16.10.3. PRODUCT PORTFOLIO 354
16.10.4. RECENT DEVELOPMENTS 354
17. RELATED REPORTS 355
List of Figures, Tables and Charts Available in North America Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
TABLE LISTTABLE 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS 52
TABLE 2 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 61
TABLE 3 NORTH AMERICA FLUDROXYCORTIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 62
TABLE 4 NORTH AMERICA TRIAMCINOLONE ACETONIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 63
TABLE 5 NORTH AMERICA FLUOCINOLONE ACETONIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 64
TABLE 6 NORTH AMERICA ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) 65
TABLE 7 NORTH AMERICA BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 66
TABLE 8 NORTH AMERICA CLOBETASONE PROPIONATE MARKET, BY REGION,
2015– 2024 (USD MILLION) 67
TABLE 9 NORTH AMERICA CLOBETASONE BUTYRATE MARKET, BY REGION,
2015– 2024 (USD MILLION) 68
TABLE 10 NORTH AMERICA HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 69
TABLE 11 NORTH AMERICA MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 70
TABLE 12 NORTH AMERICA OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION) 71
TABLE 13 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 74
TABLE 14 NORTH AMERICA ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015-2024 (USD MILLION) 75
TABLE 15 NORTH AMERICA ULTRA HIGH POTENCY CLASS MARKET, BY TYPE,
2015– 2024 (USD MILLION) 76
TABLE 16 NORTH AMERICA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 77
TABLE 17 NORTH AMERICA HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 78
TABLE 18 NORTH AMERICA MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 79
TABLE 19 NORTH AMERICA MODERATE HIGH POTENCY CLASS MARKET, BY TYPE,
2015– 2024 (USD MILLION) 80
TABLE 20 NORTH AMERICA MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 82
TABLE 21 NORTH AMERICA MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 83
TABLE 22 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 87
TABLE 23 NORTH AMERICA ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 88
TABLE 24 NORTH AMERICA DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 89
TABLE 25 NORTH AMERICA PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 90
TABLE 26 NORTH AMERICA SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 91
TABLE 27 NORTH AMERICA HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 92
TABLE 28 NORTH AMERICA MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 93
TABLE 29 NORTH AMERICA OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET,
BY REGION, 2015 – 2024 (USD BILLION) 94
TABLE 30 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015– 2024 (USD MILLION) 97
TABLE 31 NORTH AMERICA OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015-2024 (USD MILLION) 98
TABLE 32 NORTH AMERICA CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 99
TABLE 33 NORTH AMERICA LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 100
TABLE 34 NORTH AMERICA LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 101
TABLE 35 NORTH AMERICA GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 102
TABLE 36 NORTH AMERICA OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 103
TABLE 37 NORTH AMERICA PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 104
TABLE 38 NORTH AMERICA SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 105
TABLE 39 NORTH AMERICA OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 106
TABLE 40 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015– 2024 (USD MILLION) 109
TABLE 41 NORTH AMERICA HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 110
TABLE 42 NORTH AMERICA DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 111
TABLE 43 NORTH AMERICA HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 112
TABLE 44 NORTH AMERICA OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 113
TABLE 45 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) 116
TABLE 46 NORTH AMERICA HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 117
TABLE 47 NORTH AMERICA PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 118
TABLE 48 NORTH AMERICA ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 119
TABLE 49 NORTH AMERICA OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 120
TABLE 50 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 123
TABLE 51 NORTH AMERICA OVER THE COUNTER (OTC) BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) 124
TABLE 52 NORTH AMERICA PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 125
TABLE 53 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY,
2015 – 2024 (USD MILLION) 137
TABLE 54 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY,
2015– 2024 (USD MILLION) 144
TABLE 55 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) 145
TABLE 56 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) 146
TABLE 57 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) 147
TABLE 58 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) 148
TABLE 59 NORTH AMERICA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) 149
TABLE 60 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 149
TABLE 61 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 150
TABLE 62 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 151
TABLE 63 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 152
TABLE 64 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 152
TABLE 65 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 153
TABLE 66 U.S. TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 154
TABLE 67 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 154
TABLE 68 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL,
2015-2024 (USD MILLION) 155
TABLE 69 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 156
TABLE 70 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 157
TABLE 71 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 157
TABLE 72 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 158
TABLE 73 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 159
TABLE 74 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 159
TABLE 75 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 160
TABLE 76 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 161
TABLE 77 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 162
TABLE 78 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 163
TABLE 79 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 164
TABLE 80 MEXICO TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 165
TABLE 81 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 165
TABLE 82 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 166
FIGURES LIST
FIGURE 1 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: SEGMENTATION 38
FIGURE 2 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: DATA TRIANGULATION 42
FIGURE 3 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: RESEARCH SNAPSHOT 43
FIGURE 4 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET : BOTTOM UP APPROACH 45
FIGURE 5 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET : TOP DOWN APPROACH 45
FIGURE 6 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: INTERVIEW DEMOGRAPHICS 46
FIGURE 7 NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR TOPICAL CORTICOSTEROIDS AND ASIA PACIFIC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2017 TO 2024 55
FIGURE 8 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY MOLECULE NAME, SNAPSHOT 2016 60
FIGURE 9 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY POTENCY CLASS, 2016 73
FIGURE 10 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY APPLICATION, 2016 86
FIGURE 11 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY MEDICATION TYPE, 2016 96
FIGURE 12 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY END-USER, 2016 108
FIGURE 13 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET:
BY DISTRIBUTION CHANNEL, 2016 115
FIGURE 14 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY PURCHASE MODE, 2016 122
FIGURE 15 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 132
FIGURE 16 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016) 133
FIGURE 17 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY GROGRAPHY (2017 & 2024) 134
FIGURE 18 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016 & 2024) 135
FIGURE 19 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET,
BY MOLECULE NAME (2017 & 2024) 136
FIGURE 20 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 139
FIGURE 21 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET : BY COUNTRY (2016) 140
FIGURE 22 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET:
BY COUNTRY (2017 & 2024) 141
FIGURE 23 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) 142
FIGURE 24 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET,
BY MOLECULE NAME(2017 & 2024) 143
FIGURE 25 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) 331
FIGURE 26 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET:
Keyplayers in North America Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
• LEO Pharma• Glaxosmithkline Plc,
• Pfizer Inc.
Request Sample
Request Discount
